key: cord-0824397-uiyblef1 authors: Gaeta, M.; Cicero, G.; Marino, M. A.; D'Angelo, T.; Mormina, E. M.; Mazziotti, S.; Blandino, A.; Siracusano, G.; La Corte, A.; Chiappini, M.; Finocchio, G. title: EFFECTIVENESS OF BASELINE AND POST-PROCESSED CHEST X-RAY IN NONEARLY COVID-19 PATIENTS date: 2020-04-17 journal: nan DOI: 10.1101/2020.04.16.20061044 sha: ea48e40ce2ebc0e97e457612a52bfc88ac45d7ee doc_id: 824397 cord_uid: uiyblef1 Background CT is a very sensitive technique to detect pneumonia in COVID-19 patients. However, it is impaired by high costs, logistic issues and high risk of exposure. Chest x-ray (CXR) is a low-cost, low-risk, not time consuming technique and is emerging as the recommended imaging modality to use in COVID-19 pandemic. This technique, although less sensitive than CT-scan, can provide useful information about pulmonary involvement. Purpose To describe chest x-ray features of COVID-19 pneumonia and to evaluate the sensitivity of this technique in detecting pneumonia. A further scope is to assess the effectiveness of a post-processing algorithm in improving lung lesions detectability. Materials and Methods 72 patients with laboratory-confirmed COVID-19 underwent bedside chest X-ray. Two radiologists were asked to express their opinion about: (i) presence of pneumonia (negative or positive); (ii) localization (unilateral or bilateral); (iii) topography (according to pulmonary fields); (iv) density (non consolidative ground-glass or inhomogeneous opacities; consolidative nodulartype or triangular; mixed consolidative e non-consolidative); and (v) presence of pleural effusion. The point (i) was evaluated separately, while the other points in consensus. A quality assessment of post-processed x-ray images was performed by two different readers. Results The agreement about presence of pneumonia was almost perfect with K value of 0.933 and p < 0.001. Sensitivity was 69%. The following findings were seen: unilateral lung involvement in 50%; lower lung lesions in 54%; peripheral distribution in 48%; and non-consolidative pattern in 44%. Post-processed images improved the detection of lesions in 7 out 72 patients ({cong}10%) Conclusion CXR owns a good sensitivity in detecting COVID-19 lung involvement. Use of post-processing algorithm can improve detection of lesions. Our data support recommendations of the Radiological Society of North America (RSNA) to consider chest x-ray as first step imaging examination in Covid-19 patients. The role of imaging in COVID-19 patients is rapidly evolving. Transcription-polymerase chain reaction (RT-PCR) which detects viral nucleic acid is the current and only reference standard in the diagnosis of COVID-19 according to World Health Organization [1] . Several papers have demonstrated which non-contrast chest computed tomography (CT) owns high sensitivity in detecting novel COVID-19 pneumonia, also in patients with initial false negative RT-PCR, suggesting the extensive use of chest CT to decrease false negative lab studies [2-9]. Although very sensitive in detecting pneumonia, CT is not specific for COVID and increases the risks for hospital community [10] . Moreover procedures of decontamination are difficult and time consuming and can disrupt CT availability for non-COVID19 patients. For those reasons, since the beginning of the pandemic in Messina (Italy) (March 07th 2020), we have defined and started an imaging protocol for patients with COVID-19. It does not include routine CT but it is based on execution of chest x-ray (CXR) exclusively at the bed of patients after hospitalization in the COVID-center of the University Hospital of Messina. The correctness of our approach has been confirmed by the North American Radiology Scientific Expert Panel which assessed that portable CXR has to be considered as the main imaging approach in evaluating COVID patients. We have found only a paper from China describing CXR in a COVID-19 cohort of 64 patients [11] . We strongly believe that description of a further cohort of 72 patients studied with a CXR can be useful for radiologist involved in the diagnosis of COVID-19 lung involvement. The aims of this paper are: 1)to describe CXR features of COVID-19 pneumonia in a cohort of 72 consecutive COVID-19 patients diagnosed with RT-PCR; 2)to evaluate the sensitivity of this technique in detecting pneumonia. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 It is well known that a not negligible percentage of examinations performed in such a condition are not of perfect quality, mainly for the poor or absent collaboration of patients, thus a further scope of this work is related to introduce and assess the effectiveness of a state-of-the art post-processing algorithm for increasing the detectability of pulmonary lesions on CXR performed at bed. We retrieved and analyzed CXRs obtained at the bed of 72 patients admitted in our COVID-center (25 females, 47 males, age range 43-100 years, mean age 68.8 years). Each patient resulted positive for COVID-19 by RT-PCR testing (in one case biological material was obtained by bronchioloalveolar lavage -BAL). Clinically, the patients have been divided in 3 groups hospitalized in 3 different areas of our hospital according to criteria for admission in our COVID-19-center: 1)almost severe with fever, cough, slight shortness of breath at rest or under exertion (34 patients) 2)severe with reduced blood oxygen saturation (not inferior 90%) requiring oxygen therapy by mask (29 patients) 3)critical with respiratory failure requiring intubation and treatment in intensive therapy care unit (9 patients) No patients with mild symptomatology was admitted because they were kept in quarantine and treated at home unless a worsening of their symptomatology due to biphasic evolution of the disease. All the patients underwent examination within 24 hours from admission in the center (range 1-24 hours, mean 9 hours) according to their clinical conditions. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 In each patient, an anteroposterior CXR in supine position was acquired with a portable x-ray equipment. Twelve patients also had a chest CT scan performed within 48 hours before or after the admission. The indications for CT scan were : acute abdominal pain (5 patients) and evaluation of cancer pain (3 patients). Other four patients had a CT scan obtained for respiratory symptoms at outpatients centers before admission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 17, 2020. Quality was assessed by comparing case by case both the native and the post-processed CXRs. The readers 3 and 4 were asked to evaluate the improvement of lesion detectability if present. Agreement between the two readers regarding positive or negative CXR was evaluated and Kvalues were calculated. Reader 1 recorded 50 cases out of 72 as positive (69%) and 22 (31%) as negative. Reader 2 recorded 52 cases as positive (72%) and 20 as negative (28%). Agreement was almost perfect with K 0.935, p < 0.001. CXR findings were evaluated by consensus in 50 cases considered positive by both readers. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 Although CT owns a sensitivity higher than 90% in detecting Covid-19 pneumonia also in asymptomatic or slightly symptomatic patients, it is not without important drawbacks. patients ( e.g. immune-incompetent or with cancer) that needs of not deferrable CT examination (e.g. restaging of cancer). Third, the cost of CT and the limited availability of CT scanners or logistic problems could not allow the extensive use of this imaging technique. In particular, this monitoring activity could become very critical at the peak of new cases in any hospital. For those reasons, since the beginning of pandemic in our province (Messina-Italy) we started a protocol based on CXR at bed of patients admitted in our hospital. In our series, we have found a sensitivity of CXR between 69 and 72% which is good enough to state that this low-cost, low-risk technique should restrict CT as problem solving examination only. Our data support advises of North-American Radiological Society Panel Expert to avoid CT in every suspect of COVID19 patients to reduce risks and costs without a clear advantage for patients Our sensitivity is high for CXR, but such a result can be explained by considering that our admission criteria did not include patients with no or mild symptoms. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. However in our cohort bilateral and prevalent peripheral distribution of abnormalities is not so striking as in CT studies. Probably the high rate of unilateral involvement could be correlated to the lack of sensitivity for small ground-glass opacities visible only on CT (Fig. 2a, b) . In 10 out of 50 patients nodular, multi-nodular and triangular lesions could be seen (Fig. 3a, 4b-c ) . This type of lesions has been already described as atypical on CT scan [15] . This work has some limitations. First, our cohort , due to admission criteria, does not include asymptomatic or mild patients where CT scan can detect ultra-early and early findings of pneumonia [16] , and then we cannot state which is the sensitivity of CXR in these patients. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Quality of chest x-ray films obtained at bed in supine position cannot be perfect in a significant number of cases, particularly in old patients suffering of dyspnea. This limitation drove the development and clinical test of a post processing tool to improve the contrast resolution of CXR. Quality evaluation of post-processed CXRs was made either on the base of rigorous metrics (entropy) either on subjective evaluation. Both types of analyses showed a significant improvement of quality. Interestingly, in 7 cases out of 72 patients (≅10%) further lesions not detected on baseline CXR could be seen on post-processed images (Fig.5 ). In conclusion, our data show some novel characteristics of CXR findings in the most extensively group of COVID-19 patients who have to be studied during hospitalization, namely patients with not early disease: 1) CXR at bed owns a good sensitivity in detecting COVID-19 lung involvement in patients with not early disease. 2) Our data support the (RSNA) Panel Expert recommendations on imaging approach to COVID-19 pandemic based on CXR rather than protocols based on extensive use of CT [18] . 3) The use of proper post-processing tools can improve quality of CXR and detection of lesions. Page 11 of 28 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 17, 2020. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 17, 2020. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 17, 2020. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 17, 2020. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Page 24 of 28 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia CT imaging features of 2019 novel coronavirus (2019-nCoV) Emerging coronavirus 2019-nCoV pneumonia Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China In a 78 year-old male patient with fever and slight dyspnea chest x-ray shows a large non-consolidative lesion in the peripheral left lung (arrowheads). (b) Coronal reconstruction of CT-scan of the same patient performed 3 hours after, depicted small ground glass lesions in the right lung, not clearly visible on chest xray. (c) 82 year-old male patient with diffuse and bilateral lung involvement year-old male patient with bilateral lung involvement. In both lower lungs, the lesions are consolidative, nodular and triangular-shaped (arrowheads). (b) 92 year-old female patient with bilateral and diffuse involvement of upper and lower lungs